Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NETWORK × Thoracic × Clear all

Phase

Phase 2 92 Phase 3 32 Phase NA 14 Phase 1 13 Phase 1/2 11 Phase 2/3 7 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

OTHER 94 INDUSTRY 50 OTHER_GOV 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4 Other hematologic neoplasm 2 Thoracic 1 Plasma cell 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Maestro Clinical, Inc.

Phase 4 Completed

133 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡